Cochrane Home Sales Rise 34%

Written by

in

In Mid-Q3, Cochrane sales ↑~34% yearly, but benchmark price ↓~2% to ~$570K, showing stronger activity even as pricing softened slightly for buyers.
Cochrane stood out in Mid-Q3, landing among the few nearby communities where completed home sales moved higher despite softer activity across much of the area.
Cochrane's benchmark settled near $570K in Mid-Q3, showing a modest yearly pullback rather than a sharp correction as activity gained momentum locally.
Supply rose in Cochrane during Mid-Q3, adding inventory as sales improved and helping explain why benchmark pricing still eased despite stronger transaction counts.
Cochrane's Mid-Q3 numbers showed that stronger sales did not automatically translate into higher benchmark pricing, giving the local market a more nuanced read.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *